Microbial Cancer Immunotherapy Reprograms Hematopoiesis to Enhance Myeloid-Driven Anti-Tumor Immunity

Scientists demonstrated that Bacillus Calmette-Guérin administered in the bladder colonizes the bone marrow and, in both mice and humans, reprograms HSPCs to alter and amplify myelopoiesis.